INS and type 2 diabetes mellitus: These pro-inflammatory markers could inhibit insulin signalling pathways, leading to insulin resistance, dysfunction of β-cells, hyperglycaemia, and the occurrence of T2DM (Liaqat et al., 2021; Harkins et al., 2020; Descamps et al., 2019).